MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4240/wjgs.v14.i6.567

Медицинская библиотека · World journal of gastrointestinal surgery · 2022

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension.

Yan Xuan-Hui, Yue Zhen-Dong, Zhao Hong-Wei, Wang Lei, Fan Zhen-Hua, Wu Yi-Fan, Meng Ming-Ming, Zhang Ke, Jiang Li, Ding Hui-Guo, Zhang Yue-Ning, Yang Yong-Ping, Liu Fu-Quan

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients with hepatocellular carcinoma complicated with main portal vein tumor thrombosis (mPVTT) and cirrhotic portal hypertension (CPH) have an extremely poor prognosis, and there is a lack of a clinically effective treatment paradigm.

AIM: To evaluate the efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) combined with radioactive seed strand for the treatment of mPVTT patients with CPH.

METHODS

The clinical data of 83 consecutive patients who underwent TIPS combined with 125I seed strand placement for mPVTT and CPH from January 2015 to December 2018 were retrospectively reviewed. Procedure-related data (success rate, relief of portal vein pressure and CPH symptoms, and adverse events), PVTT response, and patient survival were assessed through a 2-year follow-up.

RESULTS

The success rate was 100.0% without perioperative death or procedure-related severe adverse events. The mean portal vein pressure was significantly decreased after the procedure (22.25 ± 7.33 mmHg vs 35.12 ± 7.94 mmHg, t = 20.61, P < 0.001). The symptoms of CPH were all effectively relieved within 1 mo. The objective response rate of PVTT was 67.5%. During a mean follow-up of 14.5 ± 9.4 mo (range 1-37 mo), the cumulative survival rates at 6, 12 and 24 mo were 83.1%, 49.7%, and 21.8%, respectively. The median survival time was 12.0 ± 1.3 mo (95% confidence interval: 9.5-14.5). In multivariate Cox regression analysis, body mass index, Child-Pugh grade, cTNM stage, and PVTT response were independent prognostic factors (P < 0.05).

CONCLUSION

TIPS combined with radioactive seed strand might be effective and safe in treating mPVTT patients with CPH.

Для цитирования: Yan Xuan-Hui, Yue Zhen-Dong, Zhao Hong-Wei, Wang Lei, Fan Zhen-Hua, Wu Yi-Fan, Meng Ming-Ming, Zhang Ke, Jiang Li, Ding Hui-Guo, Zhang Yue-Ning, Yang Yong-Ping, Liu Fu-Quan. Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension.. World journal of gastrointestinal surgery. 2022. DOI: 10.4240/wjgs.v14.i6.567.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.